Skip to main content
OpenTrials
Completed

NCT Number: NCT06164405

Arterial dP/dt Dependency on Loading Conditions

In the present study the investigators aim to assess the changes of the arterial dP/dtmax induced by fluids and vasoactive drugs during abdominal surgery

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Fondazione Policlinico Universitairo Agostino Gemelli

Roma, RM, 00148, Italy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients scheduled for abdominal surgery informed consent acceptance

-

Exclusion criteria

  • BMI> 30 Kg /m2;
  • Atrial Fibrillation;
  • Congestive heart failure with FE <35% and/or NYHA≥3;
  • Severe known cardiac valve disease;
  • Emergency surgery
  • Shock or any acute conditions who required admission intensive care unit

Treatment and study plan

arterial dp/dtmax

Device

to assess the variations of the arterial dp/dt max after drugs or fluids administration

Primary outcomes

  1. dp/dt fluids dependency

    Time frame: intraoperative

    measurement of dp/dtmax after fluid challenge

Sponsors and collaborators

Lead sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Other

Registry information

Official study title

RESPONSE OF ARTERIAL dP/dt TO FLUIDS AND VASOACTIVE DRUGS DURING ABDOMINAL SURGERY: A PROSPECTIVE PILOT STUDY

Acronym: REABILITY

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Dec 11, 2023
Registry last updated
Apr 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.